Welcome : Guest

Shionogi & Co., Ltd. (Japan) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Shionogi & Co., Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 266 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-01191
Price: $3500
Company Type: Public
Pages: 270
Date: September 2015
Market Data Tables: 266

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Shionogi & Co., Ltd.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Japan, Europe, North America and Others......3
Pharmaceuticals......5
Table 2: Generic Pharmaceuticals Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......5
Table 3: Leading Pharmaceuticals Suppliers to Germany by Region Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Belgium, France, Great Britain, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, USA, and Others......6
Table 4: Pharma Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Europe, Japan, North America, and Others......7
Table 5: Pharmaceuticals Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......8
Table 6: Pharmaceuticals Sales by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......9
Table 7: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2014) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......10
Table 8: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......11
Table 9: Pharmaceuticals Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Abilify, AdvairDiskus, Crestor, Cymbalta, Enbrel, Humira, Nexium, Remicade, and Others......12
Table 10: Pharmaceuticals Prescription Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Amlodipine, Hydrocodone/Acetaminophen, Levothyroxine, Lisinopril, Metformin, Metoprolol, Omeprazole, Salbutamol, Simvastatin, and Others......13
Table 11: Speciality Pharmaceuticals Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......14
Table 12: Pharmaceutical Market by Country in Europe (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......15
Table 13: Pharmaceuticals Market by Region in European Union (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Great Britain, Italy, Spain, and Others......16
Table 14: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......17
Table 15: Pharmaceuticals by Therapeutic Area in China (2014) - Percentage Market Share Breakdown by Value Sales for Alimentary & Metabolism, Anti-Infective, Cardiovascular, Central Nervous System, Neoplasm, and Others......18
Table 16: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......19
Table 17: Number of Paid Prescriptions by Statutory Health Insurance (SHI) in Germany (2014) - Percentage Market Share Breakdown by Category for Pharmaceuticals, and Others......20
Table 18: Pharmaceutical Drugs Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......21
Table 19: Pharmaceutical Consumption by Category in Australia (2014) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......22
Table 20: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......23
Table 21: Spending on Drugs by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Canada, European Union, Japan, South Korea, US, and Others......24
Table 22: Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Biologics, and Chemicals......25
Table 23: Drugs Market by Region Worldwide (2014) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......26
Table 24: Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......27
Table 25: Drug Market by Category in Asia-Pacific (2014) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......28
Table 26: Drugs Payment Market by Payer in Australia (2014) - Percentage Share Breakdown by Value Sales for Government, and Patients......29
Table 27: Government Spending on Drugs by Category in Australia (2014) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......30
Table 28: Government Spending on Drugs by Category in Australia (2014) - Percentage Market Share Breakdown by Volume for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......31
Table 29: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......32
Table 30: Therapeutics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antidiabetics, Asthma/COPD, Autolmmune, Lipid Regulators, Oncologicsm, and Others......33
Table 31: Systemic Drugs, Therapies Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for DMARDS (Disease-Modifying Antirheumatic Drugs), Non-Tumor Necrosis Factor (TNF), and Tumor Necrosis Factor (TNF)......34
Table 32: Research & Development Spending in Pharmaceuticals by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......35
Pharmaceutical Benefits Scheme (PBS) Services......36
Table 33: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Category in Australia (2014) - Percentage Share Breakdown by Value Sales for Concession Non Safety Net, Concession Safety Net, Doctor's Bag, General Non Safety, and General Safety Net......36
Table 34: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Category in Australia (2014) - Percentage Share Breakdown by Volume Sales for Concession Non Safety Net, Concession Safety Net, Doctor's Bag, General Non Safety, and General Safety Net......37
Table 35: Pharmaceutical Benefits Scheme (PBS), and Repatriation Pharmaceutical Benefits Scheme (RPBS) Services Market by Region in Australia (2014) - Percentage Share Breakdown by Value Sales for Australian Capital Territory (ACT), New South Wales (NSW), Northern Territory (NT), Queensland (QLD), South Australia (SA), Tasmania (TAS), Victoria (VIC), and Western Australia (WA)......38
Table 36: Pharmaceutical Benefits Scheme (PBS), and Repatriation Pharmaceutical Benefits Scheme (RPBS) Services Market by Region in Australia (2014) - Percentage Share Breakdown by Volume Sales for Australian Capital Territory (ACT), New South Wales (NSW), Northern Territory (NT), Queensland (QLD), South Australia (SA), Tasmania (TAS), Victoria (VIC), and Western Australia (WA)......39
OTC Drugs......40
Table 37: OTC Market (Private Label and Others) by Region Worldwide (2014) - Percentage Share Breakdown by Values Sales for Australia, Canada, Chile, France, Germany, Israel, Japan, Netherlands, Russia, United Kingdom, USA and Rest of the World......40
Table 38: OTC Drug Sales by Category in China (2014) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others......41
Table 39: OTC Drugs Market by Channel in China (2014) - Percentage Share Breakdown by Value Sales for Clinics, Community Hospital, General Hospital, Pharmacy, Supermarket, and Others......42
Prescription Drugs......43
Table 40: Prescription Drugs Market in the US (2014) in US$ Million......43
E-Prescriptions......44
Table 41: Number of e-Prescriptions (2010-2014) Routing in Million......44
Table 42: e-Prescription Adoption Rates by Small Practitioners in the US (%) - 2014......45
Table 43: e-Prescription Adoption Rates by Specialization in the US (%) - 2014......46
Table 44: US States Ranked by Safe e-Prescription Adoption Rates - 2014......47
Table 45: e-Prescription Adoption by Chain Pharmacies in US (2010-2014) (in Thousands)......48
Pharmacy Market......49
Table 46: Pharmacy Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Controlled Drugs, GSL Medicines, Drugs, Chemicals, Non-Drugs, Pharmacy only, and Prescription only......49
Antibiotics......50
Table 47: Antibiotics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......50
Table 48: Antibiotics Market by Category in China (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......51
Anticoagulants......52
Table 49: Anticoagulant Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Heparin, Low-Molecular-Weight Heparin (LMWH), Novel Oral Anticoagulants, Warfarin, and Other Injectable Anticoagulants......52
Antimetabolites......53
Table 50: Antimetabolites Market by Type Worldwide (2014) - Percentage Share Breakdown by Value for Capecitabine, Gemcitabine, Pemetrexed, TS-1, and Others......53
Antivirals......54
Table 51: Antiviral Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......54
Acne Drugs......55
Table 52: Acne Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......55
Cancer Drugs......56
Table 53: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......56
Table 54: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......57
Table 55: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......58
Chronic Lymphocytic Leukemia (CLL)......59
Table 56: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2014) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......59
Table 57: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......60
Table 58: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......61
Table 59: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......62
Chronic Myelogenous Leukemia (CML)......63
Table 60: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......63
Liver Cancer......64
Table 61: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......64
Diabetes Drugs......65
Table 62: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......65
Table 63: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......66
Table 64: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......67
Table 65: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti-Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......68
Table 66: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......69
Table 67: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......70
Table 68: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......71
Table 69: Insulin Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog) and Rh Insulin......72
Dermatological Drugs......73
Table 70: Dermatological Drug Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......73
Table 71: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......74
Table 72: Dermatology Drugs Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......75
HIV Drugs......76
Table 73: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others* (Includes NNRTIs)......76
Table 74: HIV Regimens for Experienced Patients by Segment in the US (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......77
Table 75: HIV Regimens for New Start Patients by Segment in European Union (2014) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......78
Kidney Disease Drugs......79
Table 76: Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......79
Table 77: Hemodialysis Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Mircera)......80
Table 78: Dialysis Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......81
Table 79: Chronic Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......82
Nicotine Replacement Therapy (NRT)......83
Table 80: Nicotine Replacement Therapy (NRT) Smoking Cessation Market by Product Worldwide (2014) - Percentage Share Breakdown by Value Sales for Gum, Patches, Tablets or Lozenges, and Others......83
Table 81: Nicotine Replacement Therapy (NRT) Products Market by Retail Sales in the UK (2014) - Percentage Share Breakdown for Gums, Inhalers/Sprays, Lozenges & Tablets, and Patches......84
Non Hodgkin lymphoma (NHL)......85
Table 82: Non Hodgkin lymphoma (NHL) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Rituxan, Gazyva, and Others......85
Table 83: Non Hodgkin lymphoma (NHL) Market by Category Worldwide (2014) - Percentage Share Breakdown by Volume for Burkitt Lymphoma-Burkitt Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Immunodeficiency-Associated Lymphoproliferative Disorders, Lymphoplasmacytic Lymphoma, Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma, Small Cell Lymphocytic Lymphoma-Chronic Lymphocytic Leukemia, T-Cell and Natural Killer (NK) -Cell Lymphoma, and Others......86
Table 84: No. of Indolent Non Hodgkin lymphoma (NHL) (1L) Patients by Category in the US (2014) - Percentage Share Breakdown for Rituxan, Gazyva, and Others......87
Table 85: No. of Indolent Non Hodgkin lymphoma (NHL) (R/R) Patients by Category in the US (2014) - Percentage Share Breakdown for Rituxan, Gazyva, and Others......88
Table 86: No. of Non Hodgkin lymphoma (NHL) (R/R) Patients by Category in the US (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......89
Table 87: No. of Non Hodgkin lymphoma (NHL) Patients by Category in the US (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......90
Table 88: No. of Indolent Non Hodgkin lymphoma (NHL) (1L) Patients by Category in European Union (2014) - Percentage Share Breakdown for Rituxan, Gazyva, and Others......91
Table 89: No. of Indolent Non Hodgkin lymphoma (NHL) (R/R) Patients by Category in European Union (2014) - Percentage Share Breakdown for Rituxan, Gazyva, and Others......92
Table 90: No. of Non Hodgkin lymphoma (NHL) (1L) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......93
Table 91: No. of Non Hodgkin lymphoma (NHL) (R/R) Patients by Category in European Union (2014) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......94
Table 92: Indolent Non Hodgkin lymphoma (NHL) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Rituxan, Gazyva, and Others......95
Hematological Cancer......96
Table 93: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......96
Rheumatology Drugs......97
Table 94: Rheumatology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others......97
Table 95: Rheumatology Drugs Market by Product Type in the US (2014) - Percentage Share Breakdown by Value Sales for Biologicals/TNF Inhibitors, Coxibs, DMARDS, Gout, MuscleRelaxants, NSAIDS, and Others......98
Therapeutic Biologics......99
Table 96: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......99
Table 97: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......100
Urinary Incontinence Drugs......101
Table 98: Urinary Incontinence Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......101
Table 99: Urinary Incontinence Drugs Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......102
Other Drugs......103
Table 100: Anaphylaxis Market by Product Worldwide (2014) - Percentage Share Breakdown by Value for Drug, Food, Insect and Latex......103
Table 101: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......104
Table 102: Bone Disease Drugs Market by Therapy Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bisphosphonates, Bone Oncology, Hormonal Agents, SERMS, and Others......105
Table 103: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......106
Table 104: Central Nervous System Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......107
Table 105: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2014) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......108
Table 106: Epilepsy Drugs Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......109
Table 107: Formulations Sales by Category in India (2014) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastro Intestinal, Pain Management, and Others......110
Table 108: Gastrointestinal Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......111
Table 109: Global Smoking Cessation (Nicotine Replacement Therapy & Prescription Drugs) Market (2014) in US$ Million......112
Table 110: Global Therapy and Care Market for Chronically and Critically Ill Patients by Segment (2014) - Percentage Share Breakdown by Value Sales for Clinical Nutrition, Infusion Therapy, IV Drugs, and Medical Devices......113
Table 111: GLP-1 Sales by Category in the US (2014) - Percentage Market Share Breakdown by Value for Byetta/Bydureon (AZN), Lixisenatide (SNY), and Victoza (NovoNordisk)......114
Table 112: Imi-Cila Drug Sales by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......115
Table 113: Immunostimulants Market by Type Worldwide (2014) - Percentage Share Breakdown by Value for Interferon α-2a, Lentinan, RhG-CSF, Thymopentin, Thymosin α1, and Others......116
Table 114: Infectious Disease Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......117
Table 115: Infusion Therapy Sales by Product Worldwide (2015) - Percentage Market Share Breakdown by Value for Clave Products, Custom Infusion Therapy, and Others......118
Table 116: Lipid-Lowering Drug Market by Product Category China (2015) - Percentage Share Breakdown by Value for Statins, Xuezhikang, and Other Products......119
Table 117: Meropenem Drug Sales by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......120
Table 118: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......121
Table 119: MRSA Drugs Market by Type in the US (2014) - Percentage Share Breakdown by Value Sales for Cubicin, Semi-Synthetics/SYNERCID, Tygacil, Vancomycin, Zyvox IV, and Zyvox Oral......122
Table 120: Multiple Myeloma Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......123
Table 121: Multiple Sclerosis Patient Care Expenditure by Category Worldwide (2014) - Percentage Breakdown by Value for Adaptations, Ambulatory Care, Disease Modifying Drugs, Early Retirement, Hospital Inpatient Care, Informal Care, Prescription and OTC Drugs, Services, Sick-leave and Redused Working Time, and Tests......124
Table 122: Narcotic Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......125
Table 123: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......126
Table 124: No. of e-Rx Transactions Vs Eligible Prescriptions (2011-2014) in Millions......127
Table 125: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2014) - Percentage Market Share Breakdown for GT1, and Non-GT1......128
Table 126: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2014) - Percentage Market Share Breakdown for GT1, and Non-GT1......129
Table 127: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......130
Table 128: Non-Narcotic Patch Market by Type in the US (2014) - Percentage Share Breakdown by Volume for Flector, Lidoderm, MNK-395, Pennsaid, and Voltaren Gel......131
Table 129: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......132
Table 130: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......133
Table 131: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......134
Table 132: Peritoneal Dialysis Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......135
Table 133: Piperacillin and Tazobactam (Pip Taz) Drug Sales by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for European Union, US and Rest of World......136
Table 134: Prescription Therapeutic Market by Segment in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Antibacterials, Antidiateics, Antihypertensives, Lipid Regulators, Mental Health, CNS, Pain, Respiratory Agents, and Others......137
Table 135: Proton Pump Inhibitors (PPI) Drugs Market by Category in the US (2014) - Percentage Market Share Breakdown by Value Sales for Aciphex (JNJ/Eisai), Dexilant (Takeda), Generic Prilosec, Nexium (AZN), Prevacid (Takeda), Prilosec, Protonix (PFE/WYE), and Others......138
Table 136: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......139
Table 137: Rheumatoid Arthritis Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......140
Table 138: Statutory Health Insurance (SHI) Expenditure by Category in Germany (2014) - Percentage Market Share Breakdown by Value for Dental Treatment without Tooth Replacement, Inpatient Care, Medical Treatment, Net Administration Expenses, Non-Drug Medical Aids and Equipment, Pharmaceutical Drugs, Pregnancy, Maternity, Sick Pay, Tooth Replacement, and Other Expenses......141
Table 139: Testosterone Replacement Therapy (TRT) Market by Type in the UK (2014) - Percentage Share Breakdown by Value for Capsules, Gels, Injections, and Patches......142
Table 140: Ulcer Drugs by Category in the US (2014) - Percentage Share Breakdown by Number of Prescriptions for H2 Blockers, Proton Pump Inhibitors, and Others......143
Table 141: Urology Market by Category in North America and Europe (2014) - Percentage Share Breakdown by Value for Erectile Dysfunction, Gynaecological Pain, Hypogonadism, Interstitial Cystitis / Painful Bladder Syndrome, Premature Ejaculation, Urinary Incontinence, and Urological Cancers......144
Table 142: Women's Health Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......145
Pharmaceuticals......146
Table 143: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......146
Table 144: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......147
Table 145: Market Shares of Leading Pharmacy Companies by Value Sales in Australia (2014) - Percentage Breakdown for Australian Pharmaceutical Industries (API), Sigma Pharmaceuticals Limited (SIP), Symbion Pharmacy Services, and Others......148
Table 146: Market Shares of Leading Pharmaceutical Companies in India (2014) - Percentage Breakdown by Value for Abbott India Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories, Aristo Pharmaceuticals Pvt Ltd., Cadila Pharmaceuticals Limited., Cipla Global Limited, Dr. Reddy's Laboratories., Emcure Pharmaceuticals Ltd., FDC Limited., GlaxoSmithKline Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Intas Pharmaceuticals limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Mankind Pharma, Micro Labs Ltd., Novartis AG, Pfizer Limited, India., Ranbaxy Laboratories Limited, Sanofi India Limited, Sun India Pharmacy (P) Ltd., Torrent Pharmaceuticals Limited., Unichem Laboratories, USV Limited., Wockhardt Ltd. and Others......149
Table 147: Market Shares of Leading Drug Distributors Worldwide (2014) -Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......150
Table 148: Market Shares of Leading Drug Providers in the US (2014) - Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......151
Prescription Pharmaceuticals......152
Table 149: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......152
Table 150: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......153
Table 151: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......154
Pharmaceutical Benefit Management (PBM)......155
Table 152: Market Shares of Leading Pharmacy Benefit Management (PBM) Companies Worldwide (2014) - Percentage Share Breakdown by Volume for Aetna Pharmacy Management (APM), Affiliated Computer Services, Inc., Argus Health Systems, Inc., Caremark Rx, Catamaran Corporation, Cigna Pharmacy Management, Express Scripts Holding Company, First Health Services Corporation, MedImpact Healthcare Systems, Inc., Prescription Solutions (OptumRx), Prime Therapeutics LLC, Walgreens Health Services, and Others......155
Table 153: Market Shares of Leading Pharmaceutical Benefit Management Companies by Value Sales in the US (2015) - Percentage Breakdown for Catamaran Co., CVS Health, Express Scripts Holding Co., MedImpact Healthcare Systems, Inc., OptumRx, Inc., Prime Therapeutics LLC, and Others......156
Table 154: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Company in Australia (2014) - Percentage Market Share Breakdown by Volume Sales for Alphapharm, AstraZeneca Plc, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals, Merck & Co., Inc., Novartis, Pfizer, Inc., Sanofi S.A., Wyeth, and Others......157
Full - Line Pharmacy Distributors......158
Table 155: Market Shares of Leading Full - Line Pharmacy Distributors (excluding Hospital Pharmacy Distribution) in Australia (2014) - Percentage Breakdown by Value Sales for Australian Pharmaceutical Industries (API), Sigma Pharmaceuticals Limited (SIP), and Symbion Pharmacy Services......158
Table 156: Market Shares of Leading Full - Line Pharmacy Distributors (including Hospital Pharmacy Distribution) in Australia (2014) - Percentage Breakdown by Value Sales for Australian Pharmaceutical Industries (API), Sigma Pharmaceuticals Limited (SIP), and Symbion Pharmacy Services......159
Generic Pharmaceuticals......160
Table 157: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd, Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......160
Table 158: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......161
Table 159: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......162
Table 160: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......163
Table 161: Global IV Generics Drug Market by Value Sales (2014) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......164
Table 162: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......165
Diabetes Drugs......166
Table 163: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd. and Others......166
Table 164: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......167
Insulin......168
Table 165: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......168
Table 166: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......169
Table 167: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......170
Table 168: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......171
Table 169: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......172
Table 170: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co, Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......173
Table 171: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Cadila Pharmaceuticals Limited, Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Limited, Pfizer India Limited, Ranbaxy Laboratories Limited, Sanofi India Limited, Shreya Life Sciences Pvt. Ltd, USV Limited and Wockhardt Ltd.......174
Table 172: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd. and Others......175
Fractionators with Recombinant Factor......176
Table 173: Market Shares of Leading Fractionators (With Recombinant Factors) Worldwide (2014) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Kedrion Biopharma, LFB Group, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......176
Table 174: Market Shares of Leading Fractionators (Without Recombinant Factor) Worldwide (2014) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Kedrion Biopharma, LFB Group, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......177
Gaucher Disease Drugs......178
Table 175: Market Shares of Leading Drugs for Gaucher Disease Worldwide (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......178
Table 176: Market Shares of Drugs for Gaucher Disease by Region Worldwide (2014) - Percentage Breakdown by Value for European Union, United States and Rest of World......179
Table 177: Market Shares of Leading Drugs for Gaucher Disease in the US (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......180
Table 178: Market Shares of Leading Drugs for Gaucher Disease in EU (2014) - Percentage Breakdown by Value for Cerezyme and Velaglucerase Alfa......181
Gastro Intestinal Medicines......182
Table 179: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & JohnsonPfizer, Inc., and Others......182
Table 180: Market Shares of Leading Gastrointestinal Remedy Product Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for GlaxoSmithKline plc., Johnson & Johnson, Novartis A G, Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......183
Table 181: Market Shares of Leading Gastro Intestinal Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......184
Hepatitis Drugs......185
Table 182: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......185
Table 183: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......186
Table 184: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......187
Table 185: Market Shares of Leading Hepatitis B Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Ningbo Boya Medical Equipment Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......188
Table 186: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......189
Table 187: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......190
Table 188: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......191
Injectables......192
Table 189: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......192
Table 190: Market Shares of Leading Injectable Manufacturers by Value Sales in the UK (2014) - Percentage Breakdown for Actavis Plc (Watson), AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Hospira, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......193
Table 191: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......194
Table 192: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......195
Table 193: Market Shares of Leading Injectable Manufacturers by Value Sales in Spain (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Ges Genericos Españoles Laboratorio S.A., Grifols, S.A, Hospira, Inc., Johnson & Johnson, Normon S.A., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......196
Intravenous Immunoglobulin (IVIG)......197
Table 194: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Ltd., Grifols, S.A (Incl.Talecris), and Others......197
Table 195: Market Shares of Leading Intravenous Immunoglobulin (IVIG) Providers in Europe (2015) - Percentage Breakdown by Value for Baxter International Inc., Biotest AG, CSL Ltd., Grifols, S.A (Incl.Talecris), Octapharma AG, and Others......198
Other Drugs......199
Table 196: Market Share of Leading Sport Medicine Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Arthrex, Inc., ArthroCare Corporation, Biomet, Inc., CONMED Corporation, DePuy Synthes, Smith & Nephew Plc, Stryker Corporation, and Others......199
Table 197: Market Shares of Leading Acarbose Manufacturers in China (2015) - Percentage Breakdown by Value for Bayer AG, Huadong Medicine Co., Ltd., and Luye Pharma Group Ltd.......200
Table 198: Market Shares of Leading Albumin Providers in China (2014) - Percentage Breakdown by Value for Baxter International, Inc., China Biologic Products, Inc., China National Biotec Group (CNBG), CSL Behring, Grifols, S.A., Hualan Biological Engineering, Inc., Jiangsu Kangbao Medical Equipment Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Octapharma AG, Shanghai RAAS Blood Products Co, Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co, Ltd., Tonrol Biopharm Co, Ltd., and Others......201
Table 199: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......202
Table 200: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......203
Table 201: Market Shares of Leading Anaesthetics & Analgesics Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......204
Table 202: Market Shares of Leading Artemisinin-based Combination Therapies (ACT) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Guilin Pharmaceutical Co., Ltd, Ipca Laboratories, Novartis AG, Quality Pharma Products Pvt Ltd, Sanofi S.A., and Sigma Pharmaceuticals Limited......205
Table 203: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Ltd., Lonza Group Ltd, Pfizer, Inc., Sanofi S.A., and Others......206
Table 204: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......207
Table 205: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......208
Table 206: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......209
Table 207: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......210
Table 208: Market Shares of Leading Cough/Cold Remedy Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Johnson & Johnson, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser plc., Sanofi S.A. Private Label, and Others......211
Table 209: Market Shares of Leading Cyclic Vomiting Syndrome (CVS) Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......212
Table 210: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......213
Table 211: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......214
Table 212: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......215
Table 213: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......216
Table 214: Market Shares of Leading Erectile Dysfunction (ED) Drug Brands by Value Sales in Korea (2014) - Percentage Breakdown for Cialis, Levitra, Mvix, Viagra, Yaila, and Zydena......217
Table 215: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for 3SBio, Inc., Beijing Four Rings Biopharmaceutical Co, Ltd., Kyowa Hakko Kirin Co, Ltd., North China Pharmaceutical Group Corp., Shanghai Fosun Pharmaceutical Group Co, Ltd., and Others......218
Table 216: Market Shares of Leading Flonase Drug Manufacturers in the US (2014) - Percentage Breakdown by Value for Apotex, Inc., GlaxoSmithKline Plc. and Hi-Tech Pharmacal Co., Inc., and Roxane Laboratories, Inc.......219
Table 217: Market Shares of Leading Gadeopentetate Dimengulumine Injection Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Bayer HealthCare AG, Beijing BeiLu Pharmaceutical Co., Ltd., Consun Pharmaceutical Group Ltd., General Electric Company, Shanghai Xudong Haipu Pharmaceutical Co., Ltd. and Others......220
Table 218: Market Shares of Leading Gemcitabine Companies Worldwide (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, Jiangsu Hansoh Pharmaceutical Co, Ltd., and Others......221
Table 219: Market Shares of Leading Glargine Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Pfizer India Limited, Sanofi India Limited and Wockhardt Ltd.......222
Table 220: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co, Ltd., Harbin Pharmaceutical Group Co, Ltd., Kyowa Hakko Kirin Co, Ltd., Qilu pharmaceutical Co, Ltd., Zhejiang Huahai Pharmaceutical Co, Ltd., and Others......223
Table 221: Market Shares of Leading Haemophilus B Conjugate Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hiberix), and Others......224
Table 222: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......225
Table 223: Market Shares of Leading Hemophilia Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Baxter International, Inc., Bayer AG, CSL Limited, Grifols, S.A., Kedrion S.p.A, Novo Nordisk A/S, Octapharma AG, and Pfizer, Inc.......226
Table 224: Market Shares of Leading Human Albumin Companies in China (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Chengdu Institute of Biological Products Co, Ltd., China Biologic Products, Inc., CSL Behring, Grifols, S.A., and Others......227
Table 225: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......228
Table 226: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......229
Table 227: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......230
Table 228: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......231
Table 229: Market Shares of Leading Insomnia Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Jazz Pharmaceuticals (JAZZ), Sanofi S.A. (SNY), Somaxon Pharmaceuticals, Inc. (SOMX), Takeda Pharmaceutical Company Limited, Generics, and Others......232
Table 230: Market Shares of Leading Lentinan Companies in China (2014) - Percentage Share Breakdown by Value for Jinling Pharmaceutical Company, Ltd., Nanjing Kanghai Pharmaceutical Company, Ltd., Nanjing Luye Sike Pharmaceuticals Company, Ltd., and Others......233
Table 231: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......234
Table 232: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......235
Table 233: Market Shares of Leading Narcotic Drugs Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Beijing Mundipharma Ltd., China National Medicines Corporation, Impofstoffwerk Dessau Tomau GmbH, Notheast Pharmaceutical Group ., Ltd., Shanhaiguan Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co .,Ltd., The Grunenthal Group, Weihal Lotus Pharmaceutical Co., Ltd, Wuhan HumanWell Bi-Tech industry Co, Ltd, Xian-Janseen Pharmaceutical Ltd, and Others......236
Table 234: Market Shares of Leading Nerve Growth Factor (NGF) Companies in China (2014) - Percentage Share Breakdown by Value for Ningbo Hi-Tech Biochemicals Co, Ltd., Staidson (Beijing) Biopharmaceuticals Co, Ltd., Xiamen Bioway Pku Co, Ltd., and Others......237
Table 235: Market Shares of Leading New Pharmaceutical Licensed Drug Companies by Value Sales Worldwide (2014) - Percentage Breakdown for C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Gilead Sciences, and Others......238
Table 236: Market Shares of Leading Obesity Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, and Others......239
Table 237: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......240
Table 238: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......241
Table 239: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......242
Table 240: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......243
Table 241: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......244
Table 242: Market Shares of Leading Over-The-Counter (OTC) Pharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Boehringer Ingelheim Group, Hypermarcas S.A., Procter & Gamble Pharmaceuticals, Inc., Sanofi - Medley Indústria Farmacêutica Ltda, Takeda Pharmaceutical Company Limited and Others......245
Table 243: Market Shares of Leading Paclitaxel Companies Worldwide (2014) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Nanjing Luye Sike Pharmaceuticals Co, Ltd., and Others......246
Table 244: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......247
Table 245: Market Shares of Leading Pemetrexed Companies Worldwide (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, Jiangsu Hansoh Pharmaceutical Co, Ltd., and Qilu pharmaceutical Co, Ltd.......248
Table 246: Market Shares of Leading Plasma Companies in China (2014) - Percentage Share Breakdown by Volume for Chengdu Rongsheng Pharmaceuticals Co, Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanxi Kangbao Biological Product Co, Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co, Ltd., Tonglu Biological Pharmaceutical Co, Ltd., and Others......249
Table 247: Market Shares of Leading Plasma Derivative Companies Worldwide (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Grilfols USA, Kedrion Biopharma, LFB, Octapharma AG, and Others......250
Table 248: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......251
Table 249: Market Shares of Leading Prothrombin Complex Companies in China (2014) - Percentage Share Breakdown by Value for Hualan Biological Engineering, Inc., and Shanghai Xinxing Medicine Co, Ltd.......252
Table 250: Market Shares of Leading Rabies Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Ningbo Shuanglin Mould Co, Ltd., Shuyang Group, Tonrol Biopharm Co, Ltd., and Others......253
Table 251: Market Shares of Leading Recombinant human G-CSF (rhG-CSF) Companies in China (2014) - Percentage Share Breakdown by Value for Hangzhou Jiuyuan Gene Engineering Co, Ltd., Kyowa Hakko Kirin Co, Ltd., Quit Pharma, and Others......254
Table 252: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......255
Table 253: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......256
Table 254: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co, Ltd.......257
Table 255: Market Shares of Leading Sleep Disorders Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Sanofi S.A., and Others......258
Table 256: Market Shares of Leading Specialty Drug Distributors in the US (2014) - Percentage Beakdown by Value for Catamaran Corporation, Caremark,L.L.C., Express Scripts Holding Company, OptumRx, Prime Therapeutics LLC., and Others......259
Table 257: Market Shares of Leading Tetanus Immune Globulin Manufacturers in China (2014) - Percentage Breakdown by Value for China Biologic Products, Inc., China National Biotec Group (CNBG), Hualan Biological Engineering, Inc., Nanyue Fuel Injection Systems Co, Ltd., Shuyang Group, and Tonrol Biopharm Co, Ltd.......260
Table 258: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......261
Table 259: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......262
Table 260: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......263
Table 261: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......264
Table 262: Market Shares of Leading Tropol XL Drug Manufacturers in the US (2014) - Percentage Breakdown by Value for AstraZeneca Plc., Mylan, Inc., Par Pharmaceutical Companies, Inc. (Authorized Generic), Watson Pharmaceuticals Inc. and Wockhardt Ltd.......265
Table 263: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......266
Table 264: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......267
Table 265: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......268
Table 266: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......269